The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce glycosylated hemoglobin (HbA1c, 0.5% to 1.0%), and are associated with moderate weight loss and a relatively low risk of hypoglycemia. There are differences between Asian and non-Asian populations. We reviewed available data on GLP-1RAs, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Seungjoon, Chon, Suk, Ahn, Kyu Jeong, Jeong, In-Kyung, Kim, Byung-Joon, Kang, Jun Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483602/
https://www.ncbi.nlm.nih.gov/pubmed/26124987
http://dx.doi.org/10.4093/dmj.2015.39.3.177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483602/
https://www.ncbi.nlm.nih.gov/pubmed/26124987
http://dx.doi.org/10.4093/dmj.2015.39.3.177

Ejemplares similares